489460.KQ BIOBIJOU Co.,Ltd.

Healthcare Medical Instruments & Supplies KOSDAQ
13,170 KRW
Close of Oct 31, 2026
5,610 15,325
Market cap
KRW 194B
P/E
30.3x
P/B
3.04x
ROE
17.0%
Dividend yield
0.76%
Fundamental score
1.4/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 489460.KQ undervalued?

Graham number
Price13,170
Graham value6,507
Premium102.4%

489460.KQ trades 102.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOBIJOU Co.,Ltd. fundamental analysis

7 of 22 checks passed

ROE 1/2

Moderate return on equity (17.0%), between 10% and 20%.

ROA 1/1

Return on assets (16.1%) is above the industry median (-2.3%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-42.2%) is below the industry median (-27.9%).

Revenue Growth 2/2

Revenue grew 10.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 814.4x against interest expense, well covered.

PE vs Market 0/1

PE (30.3x) is above the market median (11.3x).

PE vs Industry 0/1

PE (30.3x) is above the industry median (30.3x).

PBV 0/1

Price to book (3.0x) is above the industry median (1.2x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 92.2, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

BIOBIJOU Co.,Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOBIJOU Co.,Ltd.

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the D…

Full company profile